The potential of FDG PET/CT for early diagnosis of cardiac device and prosthetic valve infection before morphologic damages ensue

Current Cardiology Reports

Volumn 16, Issue 3, 2014, Pages

  Chen, Wengen ^a   Kim, Jongho ^a   Molchanova Cook, Olga P ^a   Dilsizian, Vasken ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac device; Cardiac imaging; Defibrillator; Endocarditis; FDG; FDG PET CT; Infection; Mechanical device; Morphologic damage; Pacemaker; PET CT; Positron emission tomography; Prosthetic valve

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR INFECTION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HEART SCINTISCANNING; HEART VALVE PROSTHESIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISOTOPE LABELING; LEAD INFECTION; OUTCOME ASSESSMENT; POCKET INFECTION; PROSTHESIS INFECTION; PROSTHETIC VALVE ENDOCARDITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; ENDOCARDITIS; INFECTION; MEDICAL RESEARCH; METHODOLOGY; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REVIEW; SCINTISCANNING;

BIOMEDICAL RESEARCH; DEFIBRILLATORS, IMPLANTABLE; EARLY DIAGNOSIS; ENDOCARDITIS; FLUORODEOXYGLUCOSE F18; HEART VALVE PROSTHESIS; HUMANS; MULTIMODAL IMAGING; PACEMAKER, ARTIFICIAL; POSITRON-EMISSION TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892960270     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0459-y     Document Type: Article

References (29)

1. Basu S, Zhuang H, Torigian DA, et al. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med. 2009;39:124-45.
2. Brinker J. Imaging for infected cardiac implantable electronic devices: a new trick for your pet. J AmColl Cardiol. 2012;59:1626-8.
3. Bertagna F, Bisleri G, Motta F, et al. Possible role of F18-FDGPET/CT in the diagnosis of endocarditis: preliminary evidence from a review of the literature. Int J Cardiovasc Imaging. 2012;28:1417-25.
4. Dilsizian V, Bacharach SL, Beanlands SR, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures: PET Myocardial Perfusion and Metabolism Clinical Imaging J Nucl Cardiol. 2009;16:651, ISSN 1532-6551 (Online) doi:10.1007/s12350-009-9094-9.
5. Dilsizian V, Taillefer R. Journey in Evolution of Nuclear Cardiology: Will There Be Another Quantum Leap with the F-18 labeledMyocardial Perfusion Tracers? J AmColl Cardiol Imaging. 2012;5:1269-84.
6. Chen W, Dilsizian V. Fluorodeoxyglucose PET Imaging of Coronary Atherosclerosis and Plaque Inflammation. Curr Cardiol Rep. 2010;12:179-84.
7. Chen W, Dilsizian V. Targeted PET/CT Imaging of Vulnerable Atherosclerotic Plaques: Microcalcification with Sodium Fluoride and Inflammation with Fluorodeoxyglucose. Curr Cardiol Rep. 2013;15:364-9.
8. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009-a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34:1013-27.
9. Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol. 2010;33:705-11.
10. Chu VH, Crosslin DR, Friedman JY, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Am J Med. 2005;118(1416):e19-24.
11. Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm. 2010;7:1043-7.
12. Pill SG, Parvizi J, Tang PH, et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty. 2006;21:91-7. (Pubitemid 44293270)
13. .• Bensimhon L, Lavergne T, Hugonnet F, et al. Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. Clin Microbiol Infect. 2011;17:836-44. The study prospectively evaluated the usefulness of FDG PET/CT for the diagnosis of device infection in 21 patients with clinically suspected device infection, and 14 controls free of infection. Compared to the gold standard of device culture after extraction or clinical follow-up, FDG PET/CT showed a high sensitivity and specificity for diagnosis of device infection, superior for pocket infection than lead infection evaluation.
14. .• Ploux S, Riviere A, Amraoui S, et al. Positron emission tomography in patients with suspected pacing system infections may play a critical role in difficult cases. Heart Rhythm. 2011;8:1478-81. The study showed the potential value of FDG-PET/CT scanning in the diagnosis of pacing lead endocarditis in 10 difficult cases with absence of valvular or lead vegetations on transthoracic and transesophageal echocardiography. FDG PET/CTshowed lead infection in 6 cases which were confirmed on subsequent culture of lead after extraction. In the 4 cases with a negative FDG PET/CT scan, the pacing system was left in place without objective signs of active lead endocarditis during follow-up. The study showed that FDG PET/CT may guide the clinical decision making for difficult cases with clinically suspected cardiac device infection.
15. .•• Sarrazin JF, Philippon F, TessierM, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616-25. The study first showed that FDG PET/CT can differentiate device infection from recent post-implant inflammation changes. FDG PET/CT findings can guide clinical management of infected cases by localizing the infection sites of superficial or deep pocket infection.
16. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394-434.
17. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200-9.
18. Hill EE, Herijgers P, Claus P, et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study. Am Heart J. 2007;154:923-8. (Pubitemid 350001280)
19. Mathew J, Anand A, Addai T, et al. Value of echocardiographic findings in predicting cardiovascular complications in infective endocarditis. Angiology. 2001;52:801-9. (Pubitemid 33139173)
20. Habib G, DerumeauxG, Avierinos JF, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33:2023-9.
21. Habib G, Hoen B, Tornos P, et al. ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-413.
22. Li JS, Sexton DJ, Mick N, et al. Proposedmodifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-8.
23. Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med. 2012;53:1235-43.
24. .•• Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18 F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61:2374-82. The study prospectively studied 72 consecutive patients suspected of having prosthesis valve endocarditis. The results showed that FDG PET/CT can detect prosthesis valve infection earlier than the echocardiography with a high sensitivity and specificity. Inclusion of abnormal FDG uptake at the site of the prosthetic valve, as a novel major criterion, can significantly increase the sensitivity of the modified Duke criteria, without compromising specificity.
25. Saby L, Le Dolley Y, Laas O, et al. Early diagnosis of abscess in aortic bioprosthetic valve by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography. Circulation. 2012;126:e217-20.
26. Schouten LR, Verberne HJ, Bouma BJ, et al. Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake. J Nucl Cardiol. 2008;15:146-7.
27. Fagman E, Perrotta S, Bech-Hanssen O, et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis. Eur Radiol. 2012;22:2407-14.
28. .• Tanis W, Scholtens A, Habets J, et al. Fusion of Cardiac Computed Tomography Angiography and 18 F-Fluorodesoxyglucose Positron Emission Tomography for the Detection of Prosthetic Heart Valve Endocarditis. J Am Coll Cardiol Imaging. 2013. doi:10.1016/j.jcmg. 2013.07.004. This was an "iPix-Imaging Vignette" in the journal with typical images showing that FDG PET/CTcould provide unique and incremental information over echocardiography and CTA in diagnosing prosthesis valve endocarditis and its complication of peri-annular abscess. Meanwhile, FDG PET/CT could confirm the diagnosis of infection by echocardiography and CTA, but provide additional information of extra-cardiac infection sites.
29. Dilsizian V, Achenbach S, Narula J. On Adding Versus Selecting Imaging Modalities for Incremental Diagnosis: A Case-Study of 18 F-Fluorodeoxyglucose PET/CT in Prosthetic Valve Endocarditis. Imaging: J AmColl Cardiol; 2013. doi:10.1016/j.jcmg.2013.07.005.